[引用][C] Effectiveness of Sacubitril/Valsartan in patients of Heart Failure with comorbidities: A retrospective real-world study
A Sachdeva, M Mayabhate, J Dali - Indian Heart Journal, 2023 - Elsevier
Effects of sacubitril/valsartan in patients with heart failure and chronic kidney disease: a meta-analysis
H Kang, J Zhang, X Zhang, G Qin, K Wang… - European journal of …, 2020 - Elsevier
Abstract Sacubitril/valsartan (LCZ696) is recommended for ejection fraction reduction in
heart failure. However, studies comparing the effects of sacubitril/valsartan in patients with …
heart failure. However, studies comparing the effects of sacubitril/valsartan in patients with …
[HTML][HTML] Renal effects of Sacubitril/Valsartan in heart failure with reduced ejection fraction: a real life 1-year follow-up study
F Spannella, M Marini, F Giulietti, G Rosettani… - Internal and emergency …, 2019 - Springer
Real-life data confirming the favourable renal outcome in patients with heart failure (HF)
treated with Sacubitril/Valsartan, previously found in several trials (RCTs), are still scant. We …
treated with Sacubitril/Valsartan, previously found in several trials (RCTs), are still scant. We …
Efficacy and safety of sacubitril/valsartan compared with ACEI/ARB on health-related quality of life in heart failure patients: a meta-analysis
H Yang, X Xu, AS Shaikh… - Annals of …, 2023 - journals.sagepub.com
Background: Data on the effects of sacubitril/valsartan compared with angiotensin-
converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARB) on health-related …
converting enzyme inhibitors/angiotensin receptor blockers (ACEI/ARB) on health-related …
Efficacy and Safety of sacubitril/valsartan in patients with heart failure
W Alhabeeb, F AlAyoubi, A Hayajneh… - International Journal of …, 2020 - ijpras.com
Objective: Clinical trial data on sacubitril/valsartan are important. Considering that real-world
data have important clinical implications, we aimed to report the efficacy and safety of …
data have important clinical implications, we aimed to report the efficacy and safety of …
[HTML][HTML] Effects and safety of Sacubitril/Valsartan (SV) on heart function and blood pressure in maintenance hemodialysis (MHD) patients
Y Wen, Y Xia, Y Gong - American Journal of Translational …, 2022 - ncbi.nlm.nih.gov
To observe the effects and safety of Sacubitril/Valsartan (SV) on heart function and blood
pressure in maintenance hemodialysis (MHD) patients with chronic heart failure (CHF). The …
pressure in maintenance hemodialysis (MHD) patients with chronic heart failure (CHF). The …
Sacubitril/valsartan improves both functional and echocardiographic parameters in patients with chronic heart failure with reduced ejection fraction
ER Cosentino, D Degli Esposti, R Miceli… - Current Medical …, 2019 - Taylor & Francis
Objective: We evaluated the clinical efficacy of sacubitril/valsartan in a group of ambulatory
patients with heart failure (HF) with reduced ejection fraction (HFrEF) referred to our HF …
patients with heart failure (HF) with reduced ejection fraction (HFrEF) referred to our HF …
Sacubitril/Valsartan: Practice Changing Guideline in the Management of Congestive Heart Failure
MA Karim, HU Siddiqui, S Ullah… - Journal of the College of …, 2017 - go.gale.com
Heart failure (HF) has been a staggering healthcare issue currently affecting more than 60
million people worldwide.** 1 Apart from non-pharmacologic interventions, the mainstay …
million people worldwide.** 1 Apart from non-pharmacologic interventions, the mainstay …
[HTML][HTML] Comparison of sacubitril/valsartan versus enalapril in the management of heart failure
S Bano, P Bai, S Kumar, N Kumar, A Ali, FNU Pariya… - Cureus, 2021 - ncbi.nlm.nih.gov
Methods This two-arm interventional study was conducted in the cardiology and internal
medicine units of a tertiary care hospital in Pakistan from July 2018 to December 2020. After …
medicine units of a tertiary care hospital in Pakistan from July 2018 to December 2020. After …